EP08.02-118 TRUST-II: A Global Phase II Study for Taletrectinib inROS1fusion Positive Lung Cancer and Other Solid Tumors.

Autor: Misako, N., Sugawara, S., Choi, C.-M., Okamoto, T., Yanagitani, N., Nosaki, K., Takahashi, T., Fujiwara, Y., Hayashi, H., Khoury, J., Nieva, J., Gabayan, A.E., Raez, L.E., Chen, H., Dimou, A., Pennell, N., Liu, G., Ou, S.-H.I., Seto, T., Ohe, Y.
Zdroj: Journal of Thoracic Oncology; 2022 Supplement, Vol. 17 Issue 9, pS458-S458, 1p
Databáze: Complementary Index